|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Endometrial effects of RU486 in normally cycling women may offer new |
| contraceptive strategies. |
| In: Proceedings of the Beijing International Symposium on Fertility Regulation, |
| Fertility Regulation: Present and Future, May 21-25, 1995, Beijing, China, edited |
| by Li Weixiong, Rose Maria Li, Hao-Chia Chen, Do Won Hahn. Bethesda, |
| Maryland, National Institutes of Health [NIH], National Institute of Child Health |
| and Human Development [NICHD], 1995. :4-30 - 4-34. |
| Progesterone is needed for the endometrial differentiation which precedes implantation. Blocking progesterone |
| action may therefore prevent implantation, inducing contraceptive action. Onapristone, lilopristone, and misoprostol |
| (RU486), synthetic steroidal compounds, interact with the progesterone receptor and demonstrate antagonist |
| properties in vivo. However, few clinical trials have evaluated antiprogestins as contraceptive agents. A range of |
| regimens could nonetheless be tested for contraceptive efficacy, based upon known dose-response effects at |
| various times in the menstrual cycle. The author discusses the various possibilities of administering RU486 during |
| the follicular or luteal phase of the cycle, chronically, intermittently or in a timed manner, or after intercourse. |
| (PubHealth.info Document ID: CONT2T 2588-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Endometrial effects of RU486 in normally cycling women |
| may offer new contraceptive strategies.", is(are) Nieman L. The source of this article is "In: Proceedings of the |
| Beijing International Symposium on Fertility Regulation, Fertility Regulation: Present and Future, May 21-25, 1995, |
| Beijing, China, edited by Li Weixiong, Rose Maria Li, Hao-Chia Chen, Do Won Hahn. Bethesda, Maryland, National |
| Institutes of Health [NIH], National Institute of Child Health and Human Development [NICHD], 1995. :4-30 - 4-34.". |
| This article was published in 1995 in English language(s). (PubHealth.info® Document ID: CONT2T 2588-06. All |
| rights reserved with PubHealth.info) PIN: 7588 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |